| Titolo |
Pubblicato in |
Anno |
| Outcomes of long‐term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis |
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION |
2020 |
| Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19 |
BRITISH JOURNAL OF HAEMATOLOGY |
2020 |
| Direct Oral Anticoagulants In Patients With Hematologic Malignancies |
HEMATOLOGICAL ONCOLOGY |
2020 |
| post filter thromboembolic prophylaxis in vena cava filter carriers |
PHLEBOLOGY |
2020 |
| Acquired FXIII deficiency and AL amyloidosis: A case of a rare association |
TRANSFUSION AND APHERESIS SCIENCE |
2020 |
| A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms |
AMERICAN JOURNAL OF HEMATOLOGY |
2020 |
| Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors |
CLINICAL DRUG INVESTIGATION |
2020 |
| Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia |
THROMBOSIS RESEARCH |
2020 |
| The treatment of upper extremities deep vein thrombosis related to thoracic outlet syndrome with direct oral anticoagulants |
PHLEBOLOGY |
2020 |
| Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial |
THE LANCET. HAEMATOLOGY |
2020 |
| Role of Factor V R2 Haplotype and Common Thrombophilia Markers as Genetic Risk Factors for Ischemic Stroke |
JOURNAL OF STROKE MEDICINE |
2020 |
| Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 |
BRITISH JOURNAL OF HAEMATOLOGY |
2020 |
| Peripherally inserted central catheter in patients with acute myeloid leukemia. Incidence and risk factors for premature removal |
LEUKEMIA & LYMPHOMA |
2020 |
| The role of an accurate diagnosis of inherited thrombocytopenia as the basis for an effective treatment. A case of MYH9 syndrome treated with a TPO-RA |
HAEMOPHILIA |
2019 |
| Direct oral anticoagulants in patients affected by major congenital thrombophilia |
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES |
2019 |
| Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma |
BRITISH JOURNAL OF HAEMATOLOGY |
2019 |
| Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: A single-center experience |
BLOOD COAGULATION & FIBRINOLYSIS |
2019 |
| Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients |
HIV MEDICINE |
2019 |
| Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus |
BLOOD TRANSFUSION |
2019 |
| OP0121 Lupus anticoagulant is associated with thrombotic events in healthy carriers: results from a prospective longitudinal study |
Annals of the Rheumatic DiseasesANNALS OF THE RHEUMATIC DISEASES |
2018 |
